Special cholesterol-lowering drugs can hamper the growth of metastasising melanoma cells if the cellular messenger substance Interleukin-6 (IL-6) is present. This link was observed in a research project funded by the Austrian Science Fund FWF, the results of which were published in the journal “Melanoma Research”. Continue reading “Cholesterol-lowering drug can kill melanoma cells”